DNTP006991
dTTP
| dNTP Pool | |
|---|---|
| Pool identifier | POOL001756 |
| Members of this Pool |
|
| Members of control pools |
|---|
| POOL001755 |
|
Last modified: 10/Sep/2021
| Results | |
|---|---|
| Publication |
Heffeter P, Popovic-Bijelic A, Saiko P, Dornetshuber R, Jungwirth U, Voevodskaya N, Biglino D, Jakupec MA, Elbling L, Micksche M, Szekeres T, Keppler BK, Gräslund A, Berger W: Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).,
Curr Cancer Drug Targets, 2009
PubMed PMCID |
| Value | 133.87 | Dimension | % |
| Error (standard deviation) | 46.37 |
| Relative compared to | control |
| Data presentation in publication | diagram |
| Source | |
|---|---|
| Source organism |
human
(Homo sapiens)
Taxonomy 9606 |
| Sample source | cell line |
| CLO Cell line name | HL-60 (NCIT:C19433) |
| Cell line/type as in publication | HL-60 acute promyelocytic cell line |
| Compartment | whole cell |
| Experiment Details | |
|---|---|
| Measurement type | HPLC-UV |
| Extraction method | acid extraction |
| Growth conditions | HL60 cells were incubated for 24 h with 2.5 μM concentrations of lanthanum(3+); 1,10-phenanthroline; thiocyanate |
| Treatment | |
|---|---|
| Drug/stress type | drug |
| PubChem | 24202211 |
| Applied drug | lanthanum(3+);1,10-phenanthroline;thiocyanate |
| Treatment details/effects | Ribonucleotide reductase (RNR) inhibitor |
| Genes and Proteins | |
|---|---|
| No genes or proteins manipulated. | |